| [1] |
WU Y J, HE S Y, CAO M D, et al. Comparative analysis of cancer statistics in China and the United States in 2024[J]. Chin Med J, 2024, 137(24): 3093-3100.
|
| [2] |
赵英楠, 高君妍, 贺子轩, 等. 中国结直肠癌早筛早诊早治高质量发展的思考[J]. 中国实用内科杂志, 2025, 45(5): 373-380.
|
| [3] |
HE D, CHEN S L, WANG X Y, et al. Icaritin represses autophagy to promote colorectal cancer cell apoptosis and sensitized low-temperature photothermal therapy via targeting HSP90-TXNDC9 interactions[J]. Adv Sci, 2025, 12(20): 2412953.
|
| [4] |
SHAO B. Autophagy-dependent apoptosis induction by oridonin are mediated by ROS-dependent AMPK-mTOR-ULK1 pathway in colon cancer[J]. Am J Cancer Res, 2025, 15(4): 1902-1918.
|
| [5] |
ALAM M, ALAM S, SHAMSI A, et al. Bax/Bcl-2 cascade is regulated by the EGFR pathway: therapeutic targeting of non-small cell lung cancer[J]. Front Oncol, 2022, 12: 869672.
|
| [6] |
TAUCHER E, MYKOLIUK I, FEDIUK M, et al. Autophagy, oxidative stress and cancer development[J]. Cancers, 2022, 14(7): 1637.
|
| [7] |
EL-KHOULY D, THABET N A, SAYED-AHMED M, et al. Promotion of autophagy and apoptosis in colorectal cancer exposed to imatinib and thymoquinone[J]. J Biochem Mol Toxicol, 2025, 39(4): e70238.
|
| [8] |
ZHOU W J, FANG C, ZHANG L W, et al. Thioredoxin domain-containing protein 9 (TXNDC9) contributes to oxaliplatin resistance through regulation of autophagy-apoptosis in colorectal adenocarcinoma[J]. Biochem Biophys Res Commun, 2020, 524(3): 582-588.
|
| [9] |
张仙宏, 李 乐. p53调控肿瘤代谢的研究进展[J]. 中国科学: 生命科学, 2023, 53(4): 431-448.
|
| [10] |
ZHENG T T, CHEN K K, ZHANG X, et al. Knockdown of TXNDC9 induces apoptosis and autophagy in glioma and mediates cell differentiation by p53 activation[J]. Aging, 2020, 12(18): 18649-18659.
|
| [11] |
JIANG Z S, SUN X G, LI Y, et al. Anlotinib induced ferroptosis through the p53/xCT/GPX4 pathway in non-small cell lung cancer[J]. Transl Oncol, 2025, 53: 102289.
|
| [12] |
王洛伟, 杜奕奇, 柏 愚, 等. 中国消化道肿瘤的早诊早治现状及挑战[J]. 中国实用内科杂志, 2025, 45(5): 353-356.
|
| [13] |
XU W L, TANG Y J, YANG Y, et al. Depletion of CPNE7 sensitizes colorectal cancer to 5-fluorouracil by downregulating ATG9B expression[J]. J Cell Mol Med, 2024, 28(8): e18261.
|
| [14] |
WANG J, PAN X T, LI J, et al. TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG[J]. Mol Med Rep, 2022, 25(6): 203.
|
| [15] |
YANG Q C, HAO N, LI R H, et al. High level of TXNDC9 predicts poor prognosis and contributes to the NF-κB-regulated metastatic potential in gastric cancer[J]. Neoplasma, 2022, 69(1): 103-112.
|
| [16] |
LU A G, WANGPU X, HAN D P, et al. TXNDC9 expression in colorectal cancer cells and its influence on colorectal cancer prognosis[J]. Cancer Investig, 2012, 30(10): 721-726.
|
| [17] |
OPYDO M, MLYCZYŃSKA A, MLYCZYŃSKA E, et al. Synergistic action of MCL-1 inhibitor with BCL-2/BCL-XL or MAPK pathway inhibitors enhances acute myeloid leukemia cell apoptosis and differentiation[J]. Int J Mol Sci, 2023, 24(8): 7180.
|
| [18] |
PALABIYIK A. The role of Bcl-2 in controlling the transition between autophagy and apoptosis (Review)[J]. Mol Med Rep, 2025, 32(1): 1-9.
|
| [19] |
ASHRAFIZADEH M, AHMADI Z, MOHAMMADINEJAD R, et al. Monoterpenes modulating autophagy: a review study[J]. Basic Clin Pharmacol Toxicol, 2020, 126(1): 9-20.
|
| [20] |
XIE Q Q, LIU Y, LI X F. The interaction mechanism between autophagy and apoptosis in colon cancer[J]. Transl Oncol, 2020, 13(12): 100871.
|
| [21] |
WU Y X, YE H P, PENG B, et al. MiR-643 functions as a potential tumor suppressor in gastric cancer by inhibiting cell proliferation and invasion via targeting TXNDC9[J]. Ann Clin Lab Sci, 2021, 51(4): 494-502.
|
| [22] |
WANG Y M, XU X, TANG J, et al. Apatinib induces endoplasmic reticulum stress-mediated apoptosis and autophagy and potentiates cell sensitivity to paclitaxel via the IRE-1α-AKT-mTOR pathway in esophageal squamous cell carcinoma[J]. Cell Biosci, 2021, 11(1): 124.
|
| [23] |
王蓓蕾, 于 洋, 韩桂玲, 等. 肺痿冲剂对肺纤维化小鼠肺纤维化、自噬与上皮间质转化的影响[J]. 郑州大学学报(医学版), 2025, 60(5): 613-617.
|
| [24] |
DEVIS-JAUREGUI L, ERITJA N, DAVIS M L, et al. Autophagy in the physiological endometrium and cancer[J]. Autophagy, 2021, 17(5): 1077-1095.
|
| [25] |
VOLIK P I, ZAMARAEV A V, EGORSHINA A Y, et al. Ally or traitor: the dual role of p62 in Caspase-2 regulation[J]. Cell Death Dis, 2024, 15: 827.
|
| [26] |
SONG C F, XU W, WU H K, et al. Photodynamic therapy induces autophagy-mediated cell death in human colorectal cancer cells via activation of the ROS/JNK signaling pathway[J]. Cell Death Dis, 2020, 11: 938.
|
| [27] |
PANATTA E, ZAMPIERI C, MELINO G, et al. Understanding p53 tumour suppressor network[J]. Biol Direct, 2021, 16(1): 14.
|
| [28] |
WEN J, WANG D L. Deciphering the PTM codes of the tumor suppressor p53[J]. J Mol Cell Biol, 2022, 13(11): 774-785.
|
| [29] |
VADDAVALLI P L, SCHUMACHER B. The p53 network: cellular and systemic DNA damage responses in cancer and aging[J]. Trends Genet, 2022, 38(6): 598-612.
|
| [30] |
YOO H S, WON S B, KWON Y H. Luteolin induces apoptosis and autophagy in HCT116 colon cancer cells via p53-dependent pathway[J]. Nutr Cancer, 2022, 74(2): 677-686.
|
| [31] |
CHATTERJEE T, GUHA D, DHAR J, et al. Adenosine dialdehyde, a methyltransferase inhibitor, induces colorectal cancer cells apoptosis by regulating PIMT: p53 interaction[J]. Biochem Biophys Res Commun, 2023, 684: 149134.
|
| [32] |
WANG H L, GUO M, WEI H D, et al. Targeting p53 pathways: mechanisms, structures and advances in therapy[J]. Signal Transduct Target Ther, 2023, 8: 92.
|